In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Humacyte Inc (NASDAQ: HUMA) closed the day trading at $4.49 up 2.51% from the previous closing price of $4.38. In other words, the price has increased by $2.51 from its previous closing price. On the day, 2.32 million shares were traded. HUMA stock price reached its highest trading level at $4.52 during the session, while it also had its lowest trading level at $4.33.
Ratios:
For a better understanding of HUMA, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.10 and its Current Ratio is at 1.10.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, H.C. Wainwright on December 11, 2023, initiated with a Buy rating and assigned the stock a target price of $6.
On August 14, 2023, Piper Sandler Upgraded its rating to Neutral which previously was Underweight and also upped its target price recommendation from $2.75 to $3.50.
On June 22, 2023, Cantor Fitzgerald started tracking the stock assigning a Overweight rating and target price of $6.Cantor Fitzgerald initiated its Overweight rating on June 22, 2023, with a $6 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Nov 19 ’24 when Niklason Laura E bought 1,797 shares for $4.44 per share. The transaction valued at 7,979 led to the insider holds 243,851 shares of the business.
Dougan Brady W bought 1,797 shares of HUMA for $7,979 on Nov 19 ’24. The Director now owns 243,851 shares after completing the transaction at $4.44 per share. On Nov 18 ’24, another insider, Niklason Laura E, who serves as the President, CEO and Director of the company, sold 811,172 shares for $4.44 each. As a result, the insider received 3,601,604 and left with 2,419,712 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, HUMA now has a Market Capitalization of 577719296 and an Enterprise Value of 562056128.
Stock Price History:
Over the past 52 weeks, HUMA has reached a high of $9.97, while it has fallen to a 52-week low of $2.43. The 50-Day Moving Average of the stock is -15.46%, while the 200-Day Moving Average is calculated to be -16.98%.
Shares Statistics:
Over the past 3-months, HUMA traded about 3.00M shares per day on average, while over the past 10 days, HUMA traded about 3502330 shares per day. A total of 128.67M shares are outstanding, with a floating share count of 103.71M. Insiders hold about 20.60% of the company’s shares, while institutions hold 27.88% stake in the company. Shares short for HUMA as of 1730332800 were 17250350 with a Short Ratio of 5.75, compared to 1727654400 on 16028146. Therefore, it implies a Short% of Shares Outstanding of 17250350 and a Short% of Float of 17.870001.
